FDA Investigator Tara L Breckenridge

Tara L Breckenridge has conducted inspections on 12 sites in 1 countries as of 08 May 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
12
Last Inspection Date:
08 May 2013
Investigator Role:
FDA Investigation Participant
Redica ID:
100000794
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Tara L Breckenridge:
Alan E Mehl, Alan L Truong, Alan M Barker, Alan P Kurtzberg, Ana Paulap Sandee, Andrew A Hoopes, Anita Narula, PhD, Anthony R Bucks, Ashley A Mutawakkil, Barbara I Rogolsky, Bei Y He, Brett R Havranek, Brittany D Terhar, Carl A Huffman, III, Chani Broner, PhD, Chilton L Ng, Chris A Sack, Christine A Harman, PhD, Christopher T Peters, Cody D Rickman, Cynthia Jim, CSO, Cynthia M Goudeau, Damaris Y Hernandez, Danial S Hutchison, David A Place, David J Eide, Dawn C Olenjack, Diane L Raccasi, Donald L Myers, Edward E Lockwood (EEL), Eric M Mueller, PharmD, Eric M Padgett, Erika V Butler, Esther C Broner, PhD, Evelyne L Weaver, Farhana Khan, Gerard T Schneider, Ginger M Sykes, Gloria J Champagne, Grace E Mcnally, Gretchen Lf Trendel, Gwyn G Dickinson, Haroon Vohra (NMI), Hector A Carrero, Helen Y Saccone, Ingrid Y Johnson, Isabel Y Espinosa, J Michael Cannon, PhD, Jacqueline Mdiaz Albertini, James D Planchon, James I Giefer, Janet B Abt, Jazmine N Still, Jeffery A Hangartner, Jill J Tillman, Joseph R Lambert, Julie N Vosilus, Kara L Roden, Karen C Daugherty, Karen G Hirshfield, Karen M Montgomery (KMM), Kathleen B Swat, Kellia N Hicks, Kelly K Nachtigal, Ken L Bowers, Kevin D Kallander, Kimberley A Hoefen, Lewis K Antwi, Linda M Cheny, Lisa L Flores, Lisa L Gilliam, Lisa L Tung, Loan Chin, Marcus F Yambot, Margaret A Smithers, Marion D Wimberly, Jr, Mariza M Jafary, Marlene G Swider, Matthew H Hunt, Matthew M Schuckmann, Matthew R Sleeter, Megan T Ziegler, Michael A Charles, Michael C Zubelewicz, Michael E Maselli, Michael J Kuchta, Michael R Goga, Michael S Araneta, Michele L Obert, Michele Perry Williams, Miranda D Mcdonald, Monica E Murie, Monica M Mcclure, Monique M Brooks, Nancy G Schmidt, Neal L Adams, Norman K Starks, Omotunde O Osunsanmi, Pamela N Agaba, Patricia A Brown, Patricia A Cortez, Paula A Trost, Prabhu P Raju, Ralph H Vocque, Regina T Brown, Richard L Rutherford, Rita K Kabaso, Robert J Ham, Robin K Reel, Roger F Zabinski, Roger L Farmer, Santiago Gallardo Johnson, Sarah E Rhoades, Scott A Golladay, Shafiq S Ahadi, Shanna R Haden, Sharon K Thoma, PharmD, Sherry G Bous, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Steve Y Rhieu, PhD, Steven D Kehoe, Steven P Donald, Susan M Jackson, Susanna E Ford, Suzanna E Ford, Tamara J Umscheid, Tara L Greene, Tara L King, Thomas J Arista, Thuy T Nguyen, LCDR, Veronica Fuentes, MS, Victoria A Wagoner, Walsworth, Warren J Lopicka, Wayne D Mcgrath, Yaodong Huang, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD, Zi Qiang Gu

Tara L Breckenridge's Documents

Publish Date Document Type Title
May, 2013 EIR TriRx Shawnee LLC - EIR, 2013-05-21
March, 2012 FDA 483 TriRx Shawnee LLC - Form 483, 2012-03-08
October, 2012 FDA 483 Hospira, Inc. - Form 483, 2012-10-24
January, 2012 EIR Sanofi - Aventis US LLC - EIR, 2012-01-27
May, 2012 EIR Celgene Corp - EIR, 2012-05-03
May, 2013 FDA 483 TriRx Shawnee LLC - Form 483, 2013-05-21
February, 2013 FDA 483 Central Admixture Pharmacy Services Inc - Form 483, 2013-02-28
January, 2012 FDA 483 Response Hospira, Inc. - Form 483R, 2012-01-25
August, 2011 FDA 483 Curia New Mexico, LLC - Form 483, 2011-08-16
January, 2012 EIR Hospira, Inc. - EIR, 2012-01-04
September, 2012 FDA 483 Consolidated Chemical, Inc. DBA CARE-TECH Laboratories, Inc. - Form 483, 2012-09-17
October, 2012 FDA 483 Response Hospira, Inc. - Form 483R, 2012-11-14
January, 2012 FDA 483 Hospira, Inc. - Form 483, 2012-01-04
October, 2012 EIR Hospira, Inc. - EIR, 2012-10-24
July, 2011 EIR Cvs Caremark - EIR, 2011-07-26
December, 2012 FDA 483 Nesher Pharmaceuticals (USA) LLC - Form 483, 2012-12-06
March, 2013 FDA 483 Curium US LLC - Form 483, 2013-03-27
March, 2013 EIR Curium US LLC - EIR, 2013-03-27
March, 2012 EIR TriRx Shawnee LLC - EIR, 2012-03-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more